Aker ASA (0MJX)
London Exchange · UK · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 1,156.00 |
|---|---|
| 52-week range | 721.00 – 1,636.09 |
| Return, 1 month / 3 months | −21.6% / −8.5% |
| Return, 1 year / 3 years | +55.3% / +121.0% |
| Trend | Below its 200-day average |
| RSI (14) | 24 |
| Volatility (1 year) | 32.4% |
| Worst drawdown (1 year) | -28.9% |
| Average daily value traded | 34.77M NOK |
| Dividend yield | 4.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aker ASA is a Norwegian industrial investment company based in Oslo. It owns and manages stakes in businesses active in oil and gas services, offshore energy, seafood and marine biotechnology, and other industrial activities. Through its holdings it takes an active ownership role, providing capital and board-level direction to the companies it controls. Its investments serve industrial and energy markets, and its portfolio companies operate internationally, serving customers in the offshore, energy and seafood industries.
The shares are listed on the London Exchange in UK under the code 0MJX, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aker ASA (0MJX) trades on the London Exchange in UK. It last closed at NOK 1,156.00 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 928 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 55.3% and over the last three months it fell 8.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.4% | ||
| From 52-week high | -28.9% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.5% | ||
| 6-month return | 12.6% | ||
| 12-month return, skipping the last month | 98.0% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.9% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 34.77M NOK | ||
| Zero-volume days | 1.7% | ||
| Income | 79 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.8% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −8.0% |
|---|---|
| 1 month | −21.6% |
| 3 months | −8.5% |
| 6 months | +12.6% |
| 1 year | +55.3% |
| 3 years | +121.0% |
| 5 years | +90.3% |
Signals
| 50-day / 200-day average | 1,440.88 / 1,172.29 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 93.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Apr 2026 | NOK 29.0000 |
| 6 Nov 2025 | NOK 26.5000 |
| 2 May 2025 | NOK 26.5000 |
| 8 Nov 2024 | NOK 35.5000 |
| 18 Apr 2024 | NOK 15.5000 |
| 7 Nov 2023 | NOK 15.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.